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OBJECTIVE — Pregnancy in type 1 diabetic women remains a high-risk situation for both
mother and child. In this study, we investigated long-term effects on body composition, prev-
alence of overweight, and insulin resistance in children of type 1 diabetic women who had had
adequateglycemiccontrolduringpregnancy(meanA1C6.2%),andwerelatedtheiroutcometo
perinatal factors, including macrosomia (birth weight 90th percentile).
RESEARCH DESIGN AND METHODS — Anthropometric measurements were per-
formed at 6–8 years of age in 213 offspring of type 1 diabetic mothers who participated in a
previousnationwidestudy.Homeostasismodelassessmentofinsulinresistance(HOMA-IR)was
determined from a fasting blood sample in 155 of these children. In addition, we studied BMI
standard deviation score (SDS) growth trajectories. Results were compared with national refer-
ence data.
RESULTS — Theprevalenceofoverweightinthestudypopulationwasnotdifferentfromthat
in the reference population. However, children who were born macrosomic showed twice as
much overweight as nonmacrosomic children. Macrosomia and maternal overweight were in-
dependentpredictorsofchildhoodoverweight.OverweightchildrenshowedanincreaseinBMI
SDS starting already after 6 months of age and had a signiﬁcantly increased HOMA-IR.
CONCLUSIONS — In type 1 diabetic women with adequate glycemic control during preg-
nancy,long-termeffectsonbodycompositionandoverweightintheiroffspringatschoolageare
limited and related mainly to macrosomia at birth. Possible targets for prevention of childhood
overweight are fetal macrosomia, maternal overweight, and an increase in BMI SDS during the
ﬁrst years of life.
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P
erinatal outcome in diabetic preg-
nancies has improved dramatically
overthepastdecades,mainlydueto
improvements in maternal glycemic con-
trolandinobstetricandneonatalcare(1).
However, despite these improvements,
pregnancyinwomenwithtype1diabetes
remains a high-risk situation for both
mother and child as we have shown in a
Dutch nationwide prospective study (2).
The incidence of maternal and neonatal
complications such as congenital malfor-
mations(9%)andmacrosomia(45%)was
still high despite good prepregnancy care
and overall adequate glycemic control
during pregnancy (mean A1C 6.2%).
Similar rates of complications have been
found in Denmark (3) and in the U.K. (4)
and have also been found in type 2 dia-
betic pregnancies (4–6). Evidence is ac-
cumulating that an altered intrauterine
environment has long-term effects on the
offspring’sdevelopment.Previousstudies
have shown the effects of a diabetic preg-
nancy on several aspects of development
intheoffspringsuchasbodycomposition
and glucose homeostasis (see ref. 7 for
an overview). However, most studies
included small or mixed study cohorts
concerning offspring of women with
pregestational type 1 and type 2 diabetes
as well as gestational diabetes mellitus.
Furthermore, most studies considered
offspring within a wide range of ages or
those born 20 years ago when glycemic
control was not as good as in current
times. Therefore, we conducted a fol-
low-up study in our nationwide Dutch
cohort of type 1 diabetic women to inves-
tigatethelong-termeffectsofcurrent(ad-
equate) control and treatment during
pregnancy on body composition, child-
hood overweight, and BMI growth trajec-
tories in their offspring at school age.
Furthermore, we related these outcomes
to perinatal factors, including macroso-
mia at birth, and investigated insulin re-
sistance to determine whether possible
effects on body composition would have
metabolic consequences already at this
young age.
RESEARCH DESIGN AND
METHODS— The study group con-
sistedofoffspringoftype1diabeticmoth-
ers (ODM) who participated in our
nationwide study on pregnancy outcome
in the Netherlands. In that study, type 1
diabetic women presenting for antenatal
care were recruited by gynecologists, in-
ternists, and diabetes nurse educators
from all 118 Dutch hospitals between 1
April 1999 and 1 April 2000. Included
were 324 infants born after 24 weeks of
gestation.Allchildrenwerebornbetween
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were six stillbirths and three neonatal
deaths, and two infants died in the ﬁrst
month after birth, leaving 313 children
eligible for follow-up.
Elements of this follow-up study pro-
tocol were a home visit for anthropomet-
ric measurements and neurocognitive
tests, a fasting blood sample on a separate
occasion after the home visit, and the col-
lection of data concerning growth pat-
terns (results from neuropsychological
evaluations will be described elsewhere).
From 313 ODM eligible for follow-up,
213 (99 boys and 114 girls) participated
in the investigations performed at home
and 155 of them agreed to additional
blood sampling. Parents of another 33
ODM provided only growth data, result-
ing in a total participation rate of 79%
(246 of 313), with 17 children lost to fol-
low-upand50nonparticipants.Themost
frequentreasonforparentsnotparticipat-
ing in the investigations at home and/or
blood sampling was the consideration
that their children were too young to be
subjected to (invasive) medical research.
Mean age of ODM at the time of measure-
mentswas6.60.2years(range6.2–7.3
years) and at the time of blood sampling
was 7.4  0.4 years (range 6.5–8.5
years). Mean time between the home visit
and blood sampling was 0.8 year (range
0.1–2.1 years). At the time of the mea-
surements, the investigator was unaware
of speciﬁc characteristics of the preg-
nancy and neonatal outcome. Informa-
tion concerning pregnancy outcome,
baseline maternal characteristics, and di-
abetes treatment during pregnancy was
subsequently obtained from the previous
study (2), and parents provided informa-
tion regarding their current height and
weight and breast-feeding in the neonatal
period. Information concerning growth
in the offspring was derived from childs
welfare clinics, which monitor growth
during childhood at 1, 2, 3, 4, 6, 71⁄2,9 ,
11, 14, 18, 24, 36, and 45 months of age.
BMI was calculated from height and
weight at these ages. This study was ap-
proved by the medical ethics committee
of the University Medical Center Utrecht,
and parents gave written informed
consent.
Measurements
The children’s height, weight, and waist
and hip circumference were measured
twice and skinfolds (biceps, triceps, su-
prailiac, and subscapular) were measured
three times at the right side of the body,
and the averages were used for analysis.
BMI and waist-to-hip ratio were calcu-
lated. All measurements were performed
by one investigator (M.R.) to exclude in-
terobserver variability. A fasting blood
sample was taken to determine glucose
andinsulinlevels.Allbloodsampleswere
analyzed at one research laboratory.
Deﬁnitions
Macrosomia was deﬁned as birth weight
90th percentile corrected for gesta-
tionalage,sex,andparityaccordingtothe
Netherlands Perinatal Registry data from
2001 (available at http://www.perinatreg.
nl). To investigate the possible effects on
outcome of different levels of macroso-
mia, we deﬁned moderate macrosomia as
birthweightbetweenthe90thand97.7th
percentileandseveremacrosomiaasbirth
weight 97.7th percentile. Maternal and
paternal educational level was catego-
rized as low, intermediate, or high ac-
cording to international standards (8).
Childhood overweight and obesity were
deﬁned according to the International
Obesity Task Force cutoff points for BMI-
for-age, which are incorporated in the
Dutch reference BMI growth diagrams
(9). The homeostasis model assessment
(HOMA) formula was used to estimate
fasting insulin resistance (HOMA-IR)
from fasting glucose and insulin levels
(10).
Statistical methods
Anthropometric measurements at 6–8
years of age and BMI data from the child
welfareclinicswereconvertedintoastan-
dard deviation score (SDS) according to
the Dutch age- and sex-speciﬁc growth
diagrams (11) using Growth Analyser 3.5
software (2007, Dutch Growth Founda-
tion). An SDS of 0 equals the age- and
sex-speciﬁc mean (or 50th percentile) of
the national reference population.
For normally distributed variables,
means  SD were used, and differences
between groups were tested by t test; oth-
erwise, median and interquartile range
and the Mann-Whitney U test were used.
For categorical variables, group differ-
ences were tested by 
2 analysis or
Fisher exact test as appropriate. The
prevalence of overweight in ODM was
compared with the national reference
data using a 
2 goodness-of-ﬁt test. Dif-
ferences between nonmacrosomic and
macrosomic ODM and between moder-
atelyandseverelymacrosomicODMwere
analyzed with analysis of variance using
age and sex (unless otherwise stated) as
covariates. If residuals were not normally
distributed, log-transformed geometric
means were compared and then back-
transformed. Multiple logistic regression
analysis was performed to determine in-
dependent predictors of childhood over-
weight with macrosomia, sex, parity,
current maternal and paternal over-
weight, low maternal and paternal educa-
tional level, mean pregnancy A1C 7%,
and breast-feeding during the ﬁrst week
as predictor variables. Results are ex-
pressed as odds ratios (ORs) with 95%
CIs. Data were analyzed using SPSS 15.0
for Windows (SPSS, Chicago, IL). P 
0.05 was considered to be statistically
signiﬁcant.
RESULTS— Maternal age, parity,
prepregnancy maternal BMI, highest
achieved educational level, ﬁrst/second/
third trimester A1C and mean A1C dur-
ing pregnancy, duration of diabetes and
prevalenceofdiabeticcomplications,pre-
eclampsia, severe hypoglycemia during
pregnancy, and cesarean section in par-
ticipating mothers were not statistically
signiﬁcantly different from those of
nonparticipating mothers. There were
no statistically signiﬁcant differences in
gestational age, sex, birth weight, or
prevalence of macrosomia, congenital
malformations, and neonatal morbidity
between participating and nonparticipat-
ing children.
Compared with the national refer-
ence population, mean SDS in ODM was
0.051.05 for height, 0.151.12 for
weight, 0.26  1.01 for weight-for-
height, 0.24  0.98 for BMI, 0.53  1.05
for waist circumference, 0.58  0.99 for
hip circumference, and 0.01  0.96 for
waist-to-hip ratio. The prevalence of both
overweight and obesity in the ODM
group was not signiﬁcantly higher than
that in the reference population at 7 years
of age (9) (15.2 vs. 13.5% for overweight
[P  0.8] and 3.8 vs. 2% for obesity [P 
0.2]). Because of the low prevalence of
obesity at this age, we considered over-
weight and obesity together as “over-
weight” for further analyses. Univariate
analysis with possible predictors of child-
hood overweight showed that the preva-
lence of macrosomia at birth and of
current maternal overweight was signiﬁ-
cantly higher in ODM who developed
overweight at 6–8 years of age (Table 1).
Multiple logistic regression analysis
showed that macrosomia and maternal
overweight were independent predictors
of childhood overweight (adjusted OR
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6.6],respectively)(Table1).HOMA-IRin
ODM (mean  SD 1.05  0.56; median
0.96 [interquartile range 0.71–1.38]) was
not higher than that of healthy 7-year-old
Dutch children (1.10  0.53; no median
mentioned) (12). There were no statisti-
cally signiﬁcant differences in mean
SDS for anthropometric measurements,
prevalence of overweight, and mean
HOMA-IR between boys and girls (data
not shown).
ODM who were macrosomic at birth
had increased height, weight, BMI, waist
and hip circumference, and thicker skin-
folds and showed more than twice as
much overweight compared with nonmac-
rosomic ODM (26 vs. 12%, P  0.01)
(Fig. 1, Table 2). Waist-to-hip ratio and
HOMA-IR did not differ between those
groups. There were no statistically signif-
icant differences in anthropometric mea-
surements,prevalenceofoverweight,and
HOMA-IR between children who had
been moderately macrosomic or severely
macrosomic at birth (Fig. 1, Table 2).
Figure 2A shows the BMI SDS growth
trajectories for macrosomic and nonmac-
rosomic ODM. A course along the base-
line in this ﬁgure equals growth along
the 50th percentile line according to the
reference BMI growth diagram (11). In
nonmacrosomic ODM, the course of the
BMI SDS was continuously around the
reference population’s mean (i.e., the
baseline).InmacrosomicODM,however,
BMI SDS initially declined in the ﬁrst
months after birth but started to rise at
7 months of age. The course of the BMI
SDS growth trajectories in children who
had been moderately macrosomic or se-
verely macrosomic at birth was similar
(datanotshown).Furthermore,wedeter-
mined HOMA-IR and the BMI SDS
growthtrajectoryinODMwhodeveloped
overweight to investigate how these dif-
fered from ODM with a normal weight at
6–8yearsofage.HOMA-IRwashigherin
overweight ODM than in normal weight
ODM (adjusted means 1.20 [95% CI
0.92–1.57] and 0.85 [0.76–0.95], re-
spectively, P  0.019), and the BMI SDS
trajectory in overweight ODM showed
(after an initial decline) an increase start-
ing already at 6 months of age (Fig. 2B).
CONCLUSIONS — The results of
this nationwide follow-up study showed
that,withadequatecontrolandtreatment
during type 1 diabetic pregnancies, the
long-term effects on body composition in
offspring at 6–8 years of age were limited
and that fasting HOMA-IR and the prev-
alence of overweight were not different
compared with those for the reference
population. Fetal macrosomia and mater-
nal overweight were independent predic-
tors of childhood overweight, and the
BMI SDS growth trajectory in children
whodevelopedoverweightshowedanin-
creasealreadyveryearlyinlife.Despitean
increased prevalence of childhood over-
weight and increased anthropometric
measurements, ODM who were macro-
somic at birth showed no increase in in-
sulin resistance. However, insulin
resistance was signiﬁcantly higher in
overweightchildrenthaninchildrenwith
a normal weight at 6–8 years of age.
Previous studies in offspring of dia-
betic mothers have shown that they are at
risk for long-term effects such as over-
weight and type 2 diabetes (7). Most of
these studies concerned mixed cohorts of
women with pregestational type 1 and
Figure1—Prevalenceofchildhoodoverweightaccordingtobirthweightpercentile.Thetotalbars
representthepercentageofODMbornperbirthweightpercentilegroup;theblackareasrepresent
the percentage of ODM with overweight at school age (*weight and thus BMI are missing for one
child in these birth weight percentile groups).
Table 1—Possible risk factors for development of childhood overweight in ODM
Normal weight Overweight P* OR (95% CI)
n 171† 40
Parity (multiparity) 47 48 0.8 0.8 (0.4–2.0)
Sex (female) 51 63 0.2 0.9 (0.4–2.2)
Mean pregnancy A1C 7% 15 21 0.5 1.4 (0.5–3.8)
Birth weight 90th percentile 47 70 0.01 4.4 (1.6–11.8)
Current maternal BMI 25 kg/m
2 37 59 0.02 2.8 (1.2–6.6)
Current paternal BMI 25 kg/m
2 49 63 0.1 1.6 (0.7–3.8)
Low maternal education 21 23 0.9 0.8 (0.2–2.4)
Low paternal education 18 30 0.1 2.7 (0.9–8.1)
Breast-feeding at 1 week 66 59 0.4 0.7 (0.3–1.6)
Dataare%oradjustedORs(95%CIs)formultiplelogisticregressionanalysis.*
2test.†Dataonweight(and
thus BMI) are missing for 2 children.
Rijpert and Associates
care.diabetesjournals.org DIABETES CARE, VOLUME 32, NUMBER 11, NOVEMBER 2009 2101type 2 diabetes as well as gestational dia-
betes mellitus. Our cohort concerned off-
spring of exclusively type 1 diabetic
women who were well prepared before
pregnancy (84% planned pregnancies
and 70% prepregnancy folic acid supple-
mentation) and achieved adequate glyce-
miccontrolduringpregnancy(meanA1C
6.2%) (2). By extrapolating Freinkel’s hy-
pothesis on fuel-mediated teratogenesis
(13), it could be hypothesized that with
adequate glycemic control during preg-
nancy, long-term outcome in the off-
spring should be better. Indeed, the
prevalence of childhood overweight in
ODM was not higher, and the effects on
body composition were minimal com-
pared with those for the reference popu-
lation,especiallyinthechildrenwhowere
born with a birth weight appropriate for
gestational age. Further follow-up and
comparison with more recent reference
data (as the reference growth diagrams
datefrom1997)shouldshowwhetherthe
slightlyhigherSDSofsomeanthropomet-
ric measurements in ODM is a result of a
continuing positive secular growth
change in the Netherlands (14) or should
be attributed to the diabetic pregnancy.
There seemed to be a clear cutoff in-
crease in the prevalence of overweight in
infantswithabirthweight90thpercen-
tile (Fig. 1). Multiple logistic regression
analysis with possible predictors for
childhood overweight showed that fetal
macrosomia, together with maternal
overweight, was indeed an independent
predictor for overweight in ODM. These
results are in accordance with other stud-
ies showing that childhood overweight
was associated with fetal macrosomia in
children of type 1 diabetic women
(15,16) and with maternal overweight as
Figure 2—BMI SDS growth trajectories in macrosomic and nonmacrosomic ODM (A) and in
overweight and normal weight ODM (B). Data are means  SEM.
Table 2—Anthropometric measurements and HOMA-IR in ODM according to level of macrosomia at birth (birth weight <90th vs. >90th
percentile and birth weight 90th–97.7th vs. >97.7th percentile)
BW 90th percentile
BW 90th
percentile P BW 90th–97.7th percentile BW 97.7th percentile P
n 103 110 46 64
Height (cm) 122.5 (121.6–123.4) 124.0 (123.0–124.9) 0.031 124.6 (123.2–126.0) 124.2 (123.1–125.3) 0.7
Weight (kg) 24.3 (23.7–24.8) 25.4 (24.8–26.0) 0.007 25.7 (24.7–26.6) 26.1 (25.3–27.0) 0.5
BMI (kg/m
2)* 15.7 (15.3–16.0) 16.6 (16.3–17.0) 0.001 16.4 (15.9–17.0) 16.7 (16.3–17.2) 0.4
Waist (cm)* 55.3 (54.3–56.3) 57.8 (56.8–58.8) 0.001 57.4 (55.8–59.0) 58.0 (56.7–59.4) 0.5
Hip (cm) 63.0 (61.9–64.0) 65.7 (64.7–66.7) 0.001 65.6 (64.0–67.2) 65.7 (64.3–67.0) 0.9
WHR 0.88 (0.87–0.89) 0.88 (0.87–0.89) 0.9 0.88 (0.87–0.89) 0.89 (0.88–0.90) 0.4
S4S (mm)* 27.9 (26.0–29.9) 31.9 (29.8–34.2) 0.006 31.0 (28.0–34.3) 32.7 (29.9–35.6) 0.4
HOMA-IR* 0.93 (0.79–1.09) 0.89 (0.79–1.01) 0.6 0.93 (0.73–1.18) 0.85 (0.68–1.05) 0.6
Numbers represent adjusted means with 95% CI or *back-transformed geometric means with 95% CI if data were log transformed for analysis. All means were
adjusted for age and sex, height was also adjusted for maternal and paternal height, and weight was also adjusted for height. BW, birth weight; S4S, sum of four
skinfolds; WHR, waist-to-hip ratio.
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tional diabetes mellitus (17,18). The
number of infants with a birth weight
20th percentile (n  6) (Fig. 1) was too
smalltodeterminewhethertherewasalso
an increased prevalence of overweight in
the low birth weight categories, as has
been found in some studies (19).
Despite differences in body composi-
tionbetweenmacrosomicandnonmacro-
somic ODM, there was no difference in
fastingHOMA-IR.Furtherfollow-upmay
showwhetherthesechildrenwilldevelop
insulin resistance or impaired insulin se-
cretion later in life. Interestingly, anthro-
pometric measurements, the prevalence
of childhood overweight, and HOMA-IR
in ODM who were severely macrosomic
atbirth(birthweight97.7thpercentile)
were not increased compared with those
of moderately macrosomic ODM (birth
weight 90th–97.7th percentile). A possi-
ble explanation for this observation could
be that glycemic control during preg-
nancy in mothers of severely macrosomic
children was not different from that in
mothers of moderately macrosomic chil-
dren (A1C 6.37  1.02 and 6.43  0.81,
respectively, P  0.7). Follow-up is nec-
essary to show possible differences in the
further development between severely
macrosomic and moderately macrosomic
children.
Breast-feeding has recently been
shown to protect against later overweight
in children of type 1 diabetic mothers
(15). In contrast, others have found that
ingestion of breast milk from diabetic
mothers, especially in the ﬁrst week of
life, may increase the risk of becoming
overweight (20). In our cohort, we did
not ﬁnd an effect of early breast-feeding
on overweight at 1 year of age (21) nor at
6–8 years of age, although our study
lacked detailed information on volume of
breast milk ingested, as was used by
Rodekamp et al. (20).
The BMI SDS growth trajectory in
ODM who had developed overweight at
school age showed an initial decline after
birth, followed by a steep rise after 6
months of age. Eriksson et al. (22) found
a similar rise in the BMI z score growth
pattern in the ﬁrst years of life in individ-
uals who developed type 2 diabetes later
inlife,especiallyiftheyhadahigherbirth
weight. In addition, in our study infants
with a high birth weight showed an initial
decline in BMI SDS followed by an in-
crease after 6 months of age (although
this increase was smaller than that in the
ODM who developed overweight at
school age). Touger et al. (23) and Silver-
man et al. (24) showed comparable
growth patterns in ODM. Based on the
ﬁndings by Eriksson et al. (22), the BMI
SDSgrowthtrajectoriesinourcohortmay
suggest that these children are at risk of
developing type 2 diabetes later in life,
although this suggestion has to be sub-
stantiatedinourpopulationatfurtherfol-
low-up. Despite the latter limitation, we
hypothesize that these ﬁndings may be
helpfulinidentifyingthosechildrenofdi-
abetic mothers who are at risk for future
health problems.
Insummary,ourﬁndingssuggestthat
in our cohort of type 1 diabetic women
with adequate glycemic control during
pregnancy, the long-term effects on body
composition of their offspring at 6–8
yearsofagearelimited.Theprevalenceof
overweight is comparable to that in the
reference population, provided that the
child is born with a birth weight appro-
priate for gestational age. However,
because of the high prevalence of mac-
rosomia and its clear association with the
development of childhood overweight,
the prevention of macrosomia remains
important, more so because overweight
children showed increased insulin resis-
tance at 6–8 years of age compared with
that in normal weight children. It is pos-
sible that continuous glucose monitoring
duringpregnancymaybeaneffectivetool
to reduce the risk of fetal macrosomia
(25).Inaddition,reducingmaternalover-
weight could be a target for the preven-
tion of childhood overweight in ODM,
and close monitoring of the infants’ BMI
SDS growth trajectory in the ﬁrst years of
life may be helpful in identifying those
ODM at risk of developing overweight
at school age. Further research is
needed to assess the possible inﬂuence
of such interventions on the prevalence
of childhood overweight in ODM.
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